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Thermodynamic functions, Gibbs energy, enthalpy and entropy for the solution processes of ibuprofen 
(IBP) in acetone and dichloromethane (DCM) were calculated from solubility values obtained at 
temperatures ranging from 293.15 K to 313.15 K. The respective thermodynamic functions for mixing 
and solvation processes as well as the activity coefficients for the solute were calculated. IBP solubility 
was high and proved similar in both solvents but was greater in DCM than acetone. In addition, the 
thermodynamic quantities for the transfer process of this drug from cyclohexane to the organic solvents 
were also calculated in order to estimate the contributions of hydrogen-bonds or of other dipolar 
interactions. The results were discussed in terms of solute-solvent interactions.
Uniterms: Ibuprofen. Solubility. Transfer. Solution thermodynamics. Organic solvents.
As funções termodinâmicas, energia de Gibbs, entalpia e entropia dos processos de solução de ibuprofeno 
(IBP) em acetona e em diclorometano (DCM) foram calculadas a partir dos valores de solubilidade, 
obtidos em intervalos de temperatura de 293,15 K a 313,15 K. As funções termodinâmicas respectivas 
para os processos de mistura e solvatação e os coeficientes de atividade para o soluto também foram 
calculados. A solubilidade do IBP foi grande e semelhante em ambos os solventes, mas, maior em DCM 
do que em acetona. Em adição, as quantidades termodinâmicas relativas ao processo de transferência 
desse fármaco do cicloexano para os solventes orgânicos foram, também, calculadas com o objetivo de 
estimar as contribuições devidas às ligações de hidrogênio ou a outras interações dipolares. Os resultados 
foram discutidos nos termos das interações soluto-solvente.
Unitermos: Ibuprofeno. Solubilidade. Transferência. Soluções termodinâmicas. Solventes orgânicos. 
INTRODUCTION
Ibuprofen (IBP) is a non-steroidal anti-inflammatory 
drug. IBP also has analgesic and antipyretic action without 
producing addiction (Roberts II, Morrow, 2001). This drug 
is widely used in current therapeutics and is administered 
mainly by the peroral route as tablets, syrups and concen-
trates (Rosenstein-Ster, 2003).
Hydrophobic drug delivery systems based on techni-
ques of microencapsulation have recently become a viable 
strategy. Microparticle systems are often prepared by emul-
sion techniques that include aqueous and organic phases; 
the drug solubility in each phase is an important value that 
needs to be determined for every microencapsulation study. 
Most microencapsulation techniques of hydrophobic drugs 
employ volatile organic solvent to dissolve the matrix poly-
mer and where possible, to also dissolve the drug. Therefore, 
it is essential to determine the drug solubility in solvents 
such as acetone and dichloromethane. The results of these 
solubility studies form the basis of most considerations 
governing the choice of the appropriate microencapsulation 
technique (Tewes et al., 2006).
As a first stage towards a more thorough understan-
ding of the molecular forces involved, the present work 
studied the thermodynamics of the solubility of IBP in two 
volatile organic solvents used for microencapsulation pro-
cesses. This study was carried out with the key purpose of 
presenting more complete and systematic information on 
the properties of dissolution and transfer for this drug. The 
solubility at several temperatures was determined in acetone 
and dichloromethane as pure solvents, and the respective 
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dissolution thermodynamic analysis was performed by 
using the Van’t Hoff and Gibbs equations. Moreover, by 
using the values reported for the IBP fusion and sublimation 
processes, the contributions of the mixing and solvation pro-
cesses to overall dissolution were also analyzed (Perlovich 
et al., 2004; Manrique, Martínez, 2007).
MATERIAL AND METHODS
Material
Ibuprofen USP (1994), acetone from A.R. Merck, 
dichloromethane A.R. (DCM) Merck and Millex®-13 mm 
filters, Millipore Corp were used in this study.
Solubility determinations
An excess of IBP was added to 20 mL of each organic 
solvent evaluated, in stoppered glass flasks. Solid-liquid 
mixtures were placed on a thermostatic mechanical shaker 
(Julabo SW23) kept at 313.15 ± 0.05 K for at least three days 
to reach equilibrium (this equilibrium time was established 
by quantifying the drug concentration until obtaining a cons-
tant value). Once at equilibrium, supernatant solutions were 
filtered (under isothermal conditions) to remove insoluble 
particles before composition analysis. Drug concentrations 
were determined by mass balance by weighing a specified 
quantity of the respective saturated solution and allowing 
solvent evaporation until a constant mass. After the pro-
cedures described above, the temperature was decreased 
by 5.0 K and stabilized at 308.15 K over at least two days, 
allowing the precipitation of the drug dissolved in excess 
and quantifying of the drug concentration in equilibrium. 
This procedure was repeated by decreasing the temperatu-
re in 5.0 K steps to reach 293.15 K. All experiments were 
performed at least three times and then averaged.
RESULTS AND DISCUSSION
The molecular structure of IBP and some of its phy-
sicochemical properties are summarized in Table I. The 
melting point, enthalpy of fusion, and enthalpy of subli-
mation were reported by Perlovich et al. (2004). This drug 
acts in solution mainly as a Lewis acid in order to establish 
hydrogen bonds with proton-acceptor functional groups 
of the solvents (oxygen in 0=C< and nitrogen in NC-). 
On the other hand, IBP can also act as a proton-acceptor 
compound by means of its carbonyl and hydroxyl moieties 
(Manrique, Martínez, 2007).
Ideal and experimental solubility of IBP 
In a first approach, the ideal solubility of a crystalline 
solute in a liquid solvent can be calculated by Eq. (1):
 (1)
where X i
2
d is the ideal solubility of the solute in 
mole fraction, DH
fus
 and DS
fus 
are the molar
 
enthalpy and 
entropy of fusion of the pure solute (at melting point), 
T
fus
 is the absolute melting point, T is the absolute solu-
tion temperature, and R is the gas constant (Manrique, 
Martínez, 2007).
Table II summarizes the experimental solubilities 
of IBP, expressed in mole fraction, in addition to the ideal 
solubilities calculated by means of Eq. (1) from DH
fus
, 
and T
fus
 presented in Table I. In almost all cases the coe-
fficients of variation for experimental solubility were less 
than 1.0%.
As shown in Table II, the IBP solubilities in both 
volatile solvents were greater than those obtained in 
other organic solvents (Garzón, Martínez, 2004). Si-
milarly, it is interesting to note that IBP solubility was 
greater than drug ideal solubility at all temperatures 
tested (except for acetone at 313.15 K), where these 
values proved greater in DCM than in acetone. Thus, it 
is evident that the highest solubility value in mole frac-
tion for IBP was obtained in DCM at 313.15 K, while 
the lowest value was found in acetone at 293.15 K. 
Unfortunately, no previous reports on solubility of IBP 
in these solvents are available, and therefore no direct 
comparison is possible. 
TABLE I - Some physicochemical properties of ibuprofen (IBP).
Molecular structure (a) M/g mol–1 (a) ΔH
fus 
/kJ mol–1 (b) T
fus 
/K (b) DH
subl 
/kJ mol–1 (b)
206.28 347.15 25.50 115.8
(a) From Budavari et al. (2001); (b) From Perlovich et al. (2004).
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IBP solubility analysis in terms of solubility 
parameters
Although experimental solubility is a complex 
phenomenon, definitions have been proposed in order to 
explain this important physicochemical property of drugs. 
One of these was proposed by Hildebrand et al. (1970) in 
terms of the solubility parameter, d, which is defined as the 
square root of cohesive energy density, and is calculated 
according to Eq. (2):
 (2)
where, DH
vap
 is the vaporization enthalpy and V is 
the molar volume. Hildebrand solubility parameters were 
initially proposed for nonpolar compounds interacting 
among them by dispersion forces (London forces). Ne-
vertheless, IBP and almost all the solvents investigated, 
interact by London forces and also by other more energetic 
forces, namely, dipolar forces and hydrogen-bonding. In 
this context, Hansen (1967) split the general d values into 
three partial parameters representing the respective con-
tributions by dispersive forces d
d
, dipolar forces d
p
, and 
hydrogen-bonding d
h
. These subparameters are related to 
total solubility parameter d
T
, as follows:
  (3)
The experimental determination of partial solubility 
parameters is not straight forward and therefore some cal-
culus methods based on the contribution of groups have 
been described. The most common methods are those pro-
posed by Fedors and van Krevelen (Barton, 1991). Table 
III summarizes IBP solubility parameters, demonstrating 
that the London forces are the most relevant for this com-
pound, which could be attributed mainly to phenyl and 
methyl moieties. Thus, based on the d
T
 value (19.4 MPa1/2), 
IBP could be considered a semipolar compound. On the 
other hand, according to the literature (Martin, Bustaman-
te, 1989; Martin et al., 1993), the greatest drug solubility 
value should be found in solvents which have similar d va-
lues. Accordingly, Table IV also summarizes the d values 
for the organic solvents tested (Barton, 1991).
Apparently, some similarity across all d values is 
evident on comparing IBP and the solvents tested (Tables 
III and IV), in particular for d
T
, d
d
 and d
h
, although no si-
milarity was found for d
p
. This fact demonstrates that the 
solubility of drug compounds is a more complex pheno-
menon than that described solely by solubility parameters 
without considering other physicochemical properties of 
solvents and solutes.
IBP activity coefficients 
The solute activity coefficient in the solution (g
2
) is 
calculated as X i
2
d/X
2
 and is an indication of the deviation 
presented by IBP from its ideal behavior (Manrique, 
Martínez, 2007). Table V shows activity coefficients as 
a function of temperature. Again, it is interesting to note 
that g
2
 values for both solvents are lower than unit values 
(except in acetone at 313.15 K) and increase with rises 
in temperature, apparently indicating a more ideal drug 
solution behavior at increasing temperatures.
From the g
2 
values presented in Table V, an appro-
ximate estimation of solute-solvent intermolecular inte-
ractions can be made based on the following expression:
 (4)
where w
11
, w
22
 and w
12
 represent the solvent-solvent, 
solute-solute and solvent-solute interaction energies, 
respectively; V
2
 is the molar volume of the supercooled 
liquid solute, and finally, f
1
 is the volume fraction of the 
solvent. In a first approach, the term (V
2
f
1
2/RT)
T,P
 may be 
considered approximately constant at the same tempe-
rature, and then g
2
 depends almost exclusively on w
11
,
 
w
22
 and w
12
 (Kristl, Vesnaver, 1995). While the term w
12
 
term favors the solution process, both w
11
 and w
22
 terms 
are unfavorable for solubility. The contribution of w
22
 
represents the work necessary to transfer drug molecules 
from the solid to the vapor state and is therefore constant 
in both organic solvents.
TABLE II - IBP experimental solubility in two volatile organic solvents expressed in mole fraction and ideal solubility at several 
temperatures
Solvent Temperature
293.15 K 298.15 K 303.15 K 308.15 K 313.15 K
Acetone 0.2333 (0.0009) 0.2689 (0.0006) 0.3121 (0.0015) 0.3520 (0.0018) 0.3932 (0.0024)
DCM 0.2762 (0.0014) 0.3021 (0.0027) 0.3383 (0.0018) 0.3793 (0.0011) 0.4107 (0.0025)
Ideal 0.2245 0.2607 0.3020 0.3489 0.4023
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Both tested solvents are volatile and have low so-
lubility parameters, which imply low w
11
 values, whereas 
w
22
 value is also relatively low, based on ΔH
fus
 and T
fus
 
values (Table I). For these reasons, in order to obtain g
2
 
values near to unit values,  large w
12
 values would also be 
required for this drug in these solvents.
Thermodynamic functions of solution 
According to Van’t Hoff analysis, the apparent 
standard enthalpy change of solution is obtained from 
the slope of ln X
2
 vs. 1/T plot (Garzón, Martínez, 2004). 
Nevertheless, in recent thermodynamic treatments some 
modifications have been introduced in the Van’t Hoff equa-
tion in order to diminish the propagation of uncertainties 
and consequently to separate the chemical effects from 
those due to statistical treatments used when enthalpy-
entropy compensation plots are constructed. Hence, the 
mean harmonic temperature (T
hm
) is used in the Van’t 
 
Hoff analysis. T
hm
 is calculated as n/
n
S
i=1
(1/T ), where n is the
 
number of temperatures studied (Krug et al., 1976). In the 
present case, the T
hm
 value obtained is only 303 K. The 
modified, more widely used expression is the following 
(Bustamante et al., 1998):
 (5)
The modified Van’t Hoff plot for IBP in the solvents 
tested is presented in Figure 1. In general, linear regression 
models with good determination coefficients were obtai-
ned in both cases studied.
The apparent standard free energy change for the so-
lution process (DG0
so
ap
ln
p), considering the approach proposed 
by Krug et al. (1976) is calculated by:
 (6)
in which, the intercept used is the one obtained 
in the analysis by treatment of ln X
2
 as a function of 
1/T – 1/T
hm
. Finally, the standard entropic change for the 
solution process (DS0
soln
) is obtained from the respective 
DH 0
soln
 and DG0
soln
 values by using:
 (7)
TABLE III - Application of the Fedors and van Krevelen methods for estimating molar volume, and Hansen partial solubility 
parameters and Hildebrand total solubility parameter for IBP
Group Quantity Fedors (a) Van Krevelen (b)
V/cm3 mol–1 F
d 
/J1/2 cm3/2 mol–1 F
p
2/J cm3 mol–2 U
h 
/J mol–1
–COOH 1 1 × 28.5 1 × 530 (1 × 420) 2 1 × 10000
–CH
3
3 3 × 33.5 3 × 420 (3 × 0) 2 3 × 0
–CH
2
– 1 1 × 16.1 1 × 270 (1 × 0) 2 1 × 0
>CH– 2 2 × –1.0 2 × 80 (2 × 0) 2 2 × 0
Disubstituted phenyl 1 1 × 52.4 1 × 1270 (1 × 110) 2 1 × 0
195.5 3490 188500 10000
d
d
 = (3490/195.5) 
= 17.9 MPa1/2 (c)
d
p
 = ((188500)1/2/195.5) 
= 2.2 MPa1/2 (d)
d
h
 = (10000/195.5)1/2 
= 7.2 MPa1/2 (e)
d
T
 = (17.92 + 2.22 + 7.22)1/2 = 19.4 MPa1/2 (f)
(a) Calculated according to values reported by Fedors (1974). (b) Calculated according to values described by Barton (1991). 
(c) Hansen dispersion forces partial solubility parameter. (d) Hansen dipolar forces partial solubility parameter. (e) Hansen hydrogen 
bonding partial solubility parameter. (f) Hildebrand total solubility parameter.
TABLE IV - Molar volume and partial and total solubility parameters at 298.15 K for the solvents tested (Barton, 1991)
Compound V/cm3 mol–1 d
d 
/MPa1/2 d
p 
/MPa1/2 d
h 
/MPa1/2 d
T
 /MPa1/2
Acetone 74.0 15.5 10.4 7.0 20.0
DCM 63.9 18.2 6.3 6.1 20.3
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Table VI summarizes the apparent standard thermo-
dynamic functions for the experimental solution process 
of IBP in the organic solvents investigated, including 
those functions for the ideal process. In order to calculate 
the thermodynamic magnitudes of experimental solu-
tion processes, some methods to calculate uncertainties 
propagation, were used (Bevington, 1969). In particular, 
the total uncertainties were obtained as the square root 
of the sum of the individual uncertainties squared. The 
standard free energy of solution was found to be posi-
tive in all cases; i.e., the solution process apparently is 
not spontaneous, which may be explained in terms of 
the concentration scale used (mole fraction), where the 
reference state is the ideal solution having the unit as 
concentration of IBP (the solid pure solute). On the other 
hand, it is  noteworthy that all the solution thermodyna-
mic quantities in acetone are similar to those obtained 
for the ideal solution process.
With the aim of comparing the relative contributions 
of enthalpy (%z
H
) and entropy (%z
TS
) to the solution pro-
cess, equations (8) and (9) were employed, respectively 
(Perlovich et al., 2004):
 (8)
 (9)
From Table VI, it follows that in all cases the solu-
tion enthalpy contributes to a greater extent to Gibbs ener-
gy of the IBP solution processes, than does the solution 
entropy. Interestingly, enthalpy and entropy contributions 
for both solvents are almost equal to those obtained for the 
ideal solution process.
Thermodynamic functions of mixing 
It is well known that the solution process may be 
represented by the following hypothetical stages (Manri-
que et al., 2008):
Solute
(Solid)
 → Solute
(Liquid)
 → Solute
(Solution)
where, the respective partial processes involved in 
drug dissolution are solute fusion and mixing at the same 
temperature (303 K), which permits calculation of the 
partial thermodynamic contributions to the overall solution 
process by means of equations (10) and (11), respectively.
 (10)
FIGURE 1 - Van’t Hoff plot for IBP solubility in acetone (□) and DCM (○).
TABLE V - IBP activity coefficients in two volatile organic solvents at several temperatures
Solvent Temperature
293.15 K 298.15 K 303.15 K 308.15 K 313.15 K
Acetone 0.962 0.969 0.967 0.991 1.023
DCM 0.813 0.863 0.892 0.920 0.979
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 (11)
where, DH 3
f
0
u
3
s
 and DS 3
f
0
u
3
s
 represent the thermodynamic 
functions of the fusion process at the harmonic tempera-
ture (303 K). Nevertheless, for practical purposes, DH 0
so
id
ln
 
and DS 0
so
id
ln
 values (Table VI) were used instead of DH 3
f
0
u
3
s
 
and DS 3
f
0
u
3
s
 as has been done previously in other studies 
(Manrique, Martínez, 2007; Manrique et al., 2008; Triana 
et al., 2009). The thermodynamic functions of mixing of 
IBP are summarized in Table VII.
The partial contributions of ideal solution (related 
to solute fusion process) and mixing processes to the en-
thalpy and entropy of drug solution, shows that DH 0
so
id
ln
 and 
DS 0
so
id
ln
 are positive (Table VI), whereas the contribution of 
the thermodynamic functions relative to the mixing pro-
cess to the solution process is negative. It can be concluded 
that the solution process of this drug in these solvents is 
driven by the solution entropies and by the mixing enthal-
pies (based on the positive DS 0
soln
 values presented in Table 
VI and the negative DH 0
mix
 values presented in Table VII).
The net variation in  DH 0
mix
 values results from the 
contribution of several kinds of interactions. The enthalpy 
of cavity formation (required for solute accommodation) is 
endothermic because energy must be supplied against the 
cohesive forces of the solvent. This process decreases so-
lubility. On the other hand, the enthalpy of solute-solvent 
interaction is exothermic and results mainly from van der 
Waals and Lewis acid-base interactions. Thus, the negative 
values obtained for enthalpy and entropy of mixing for IBP 
in both solvents, could indicate that the hydrogen bonds 
established between IBP and these solvents are much gre-
ater than the solvent-solvent intermolecular interactions, 
which leads to energy release during the mixing processes.
Thermodynamic functions of solvation
In addition to the hypothetic fusion-mixing stages 
outlined previously, the solution process may also be re-
presented by the following hypothetical stages (Manrique 
et al., 2008):
Solute
(Solid)
 → Solute
(Vapor)
 → Solute
(Solution)
where, the respective partial processes contributing 
to the solution process, are in this case, sublimation and 
solvation. This treatment allows calculation of the partial 
thermodynamic contributions to the solution process by 
means of equations (12) and (13), respectively, while the 
Gibbs energy of solvation is calculated using equation 
(14):
  (12)
  (13)
  (14)
where, DH 0
sobl 
= 115.8 kJ mol–1 was taken from Per-
lovich et al. (2004) and therefore, the function  DH 0
solv
 was 
calculated from  DH 0
soln
 values presented in Table VI. The 
respective Gibbs energy ( DG 0
sobl
 = 43.1 kJ mol–1) and en-
tropy of sublimation ( DS 0
sobl
 = 240.1 J mol–1 K–1) at 303 K 
TABLE VI - Apparent thermodynamic functions for solution process of IBP in volatile organic solvents including ideal process at 
303 K
Solvent DG 0
soln
/kJ mol-1 DH 0
soln
/kJ mol-1 DS 0
soln
/J mol-1 K-1 TDS 0
soln
/kJ mol-1 %z
H
 (a) %z
TS
 (a)
Acetone 2.98 (0.01) 20.1 (0.3) 56.4 (0.8) 17.09 (0.23) 54.0 46.0
DCM 2.73 (0.01) 15.6 (0.3) 42.4 (0.8) 12.86 (0.24) 54.8 45.2
Ideal 3.0 22.2 63.5 19.2 53.6 46.4
(a) %z
H
 and %z
TS
 are the relative contributions by enthalpy and entropy toward Free energy of solution. These values were calculated 
by means of equations (8) and (9), respectively.
TABLE VII - Thermodynamic functions for mixing process of IBP in volatile organic solvents at 303 K
Solvent DG 0
mix
/kJ mol-1 DH 0
mix
/kJ mol-1 DS 0
mix
/J mol-1 K-1 TDS 0
mix
/kJ mol-1 %z
H
 (a) %z
TS
 (a)
Acetone –0.04 –2.19 –7.1 –2.1 50.5 49.5
DCM –0.29 –6.66 –21.0 –6.4 51.1 48.9
(a) %z
H
 and %z
TS
 are the relative contributions by enthalpy and entropy toward Free energy of mixing. These values were calculated 
by means of equations analogous to equations (8) and (9), respectively.
Thermodynamic study of the solubility of ibuprofen in acetone and dichloromethane 233
were taken from the literature (Manrique, Martínez, 2007). 
The thermodynamic functions of solvation are presented in 
Table VIII, whereas to compare the relative contributions 
of enthalpy (%z
H
) and entropy (%z
TS
) to the solvation 
process, two equations analogous to equations (8) and (9) 
were employed.
Based on the values of %z
H
 and %z
TS
 presented in 
Table VIII, it follows that the main contributing force to 
standard Gibbs energy of the solvation process of IBP in 
the volatile solvents tested is enthalpy (%z
H
 are greater 
than 62%).
On the other hand, because not only the main driving 
force of solvation process of drug compounds is important, 
but also the balance between specific and non-specific so-
lute-solvent interactions, some parameters which describe 
the relative ratio of specific and non-specific solute-solvent 
interaction in terms of enthalpies (%e
H
) and  entropies 
(%e
S
), were used according to the following definitions 
introduced by Perlovich et al. (2004):
 (15)
 (16)
where, DH 0
spec
 = DH 0
soln(Org)
 – DH 0
soln(CH) 
=
 
DH 0
soln(CH→Org)
, 
DH0
non–spec
 = DH0
soln(CH)
 – DH0
subl
 = DH0
solv(CH)
, DS0
spec
 = DS0
soln(ORg)
 – DS 0
soln(CH) 
=
 
DS 0
soln(CH→Org)
, and finally,
 
DS 0
non–spec
 = DS 0
soln(CH)
.
Cyclohexane (CH) was chosen as an “inert” solvent, 
which interacts with drug molecules solely by non-specific 
interactions (dispersion forces), while the volatile solvents 
tested interact with IBP through specific interactions such 
as hydrogen bonding or other dipole-dipole forces. So-
lution thermodynamic quantities of IBP in cyclohexane 
at 303 K are DG 0
soln(CH) 
= 4.75 kJ mol–1, DH 0
soln(CH)
= 49.4 
kJ mol–1, and DS 0
soln(CH) 
= 147.4 (Garzón, Martínez, 2004; 
Manrique, Martínez, 2007).The %e
H
 and %e
S
 values for 
IBP solvation are also shown in Table VIII. These values 
indicate that during dissolution of IBP in the solvents 
studied, the specific solute-solvent interactions (chiefly 
hydrogen bonding) effectively affect the entropic term of 
Gibbs energy with respect to non-specific interactions, in 
particular in DCM (%e
S 
 ≈ 71%). With regard to the en-
thalpic term, the non-specific solute-solvent interactions 
dominate in both solvents because it is lower than 51%. 
The results obtained for the last properties of this drug in 
both tested solvents, are different in magnitude to those 
obtained in other organic solvents with different hydrogen 
bonding capability (Garzón, Martínez, 2004), although the 
reasons for this behavior are unclear.
Apparent thermodynamic functions of IBP 
transfer from cyclohexane to other organic 
solvents
In order to contribute with the generation and sys-
tematization of thermodynamic quantities of transfer, 
useful in QSAR studies, as well as in novel pharmaceu-
tical dosage forms design, these values were calculated 
for the transfer of IBP from CH to the volatile organic 
solvents tested.
Table IX depicts Gibbs energy, enthalpy and entropy 
of transfer including the respective %z
H
 and %z
TS
 values. 
The thermodynamic quantities were calculated as the di-
fference between the IBP solution functions in the organic 
solvents (Table VI) and those for CH presented in the 
literature (Garzón, Martínez, 2004; Manrique, Martínez, 
2007). According to Table IX, the transfer process of this 
drug from CH to both volatile organic solvents is sponta-
neous (DG0
CH→Org
< 0) and driven by enthalpy (DH0
CH→Org
< 0). 
On the other hand, the enthalpy and the entropy contribute 
in similar proportions to the transfer process although the 
contribution is slightly greater for enthalpy (%z
H 
 ≈ 51.5%).
In the net drug transfer process between hydrocarbons 
and organic solvents with hydrogen-bonding capability as 
donors or acceptors or other dipole-dipole interactions, the 
enthalpic and entropic changes imply energetic require-
ments and the molecular randomness (increase or decrease 
TABLE VIII - Thermodynamic functions for solvation process of IBP in volatile organic solvents at 303 K
Solvent DG 0
solv
/kJ mol-1 DH 0
solv
/kJ mol-1 DS 0
solv
/J mol-1 K-1 TDS 0
solv
/kJ mol-1 %z
H
 (a) %z
TS
 (a) %e
H
 (b) %e
S
 (b)
Acetone –40.1 –95.7 –183.7 –55.7 63.2 36.8 44.2 61.7
DCM –40.4 –100.2 –197.7 –59.9 62.6 37.4 50.9 71.2
(a) %z
H
 and %z
TS
 are the relative contributions by enthalpy and entropy toward Free energy of solvation. These values were 
calculated by means of equations analogous to equations (8) and (9), respectively. (b) %e
H
 and %e
S
 are the relative ratio of specific 
and non specific solute-solvent interactions expressed in terms of enthalpy and entropy. These values were calculated by means of 
equations (15) and (16), respectively.
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in the molecular disorder), respectively. In general terms, 
the behavior presented in each phase should be considered 
independently, before and after the transfer process.
Since hypothetically the solute is initially present 
only in the hydrocarbon phase, then the generation of a 
cavity in the dipolar organic medium in order to accommo-
date the solute after the transfer process is required. This 
is an endothermic phenomenon, since an energy supply is 
necessary to overcome the solvent-solvent interaction of 
dipolar organic solvent molecules. When the solute mo-
lecules are accommodated in the dipolar organic phase, a 
quantity of energy is released, mainly due to formation of 
hydrogen bonds (or other dipolar interactions) between 
the molecules of the drug and the solvent. 
On the other hand, after a certain number of solute 
molecules have migrated from the hydrocarbon to the 
dipolar organic phase to achieve hypothetical equili-
brium, the original cavities occupied by the drug in the 
hydrocarbon phase become occupied by CH molecules. 
This event produces an energy release due to CH-CH in-
teractions. Thus, the negative enthalpy values of transfer 
obtained could be explained by strong interactions due to 
hydrogen-bonding (or other dipolar interactions) among 
IBP and the dipolar solvents, which also diminish entropy 
by drug immobilization within these solvents. 
CONCLUSIONS
Based on the topics discussed above it can be conclu-
ded that the solution process of IBP in the volatile organic 
solvents studied is complex and depends on the nature 
of the solvent. Finally,  the data presented in this report 
contributes to  the body of physicochemical information 
available on the solubility of this extensively used anti-
inflammatory drug.
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